Mèze, France
InvestigatioN of a Smart Probe for Lung lEsion Characterization Using Impedance Technology
Participants in this study require a lung biopsy to confirm if they have a lung tumour. A biopsy is a procedure where a piece of lung tissue is removed for testing. Current biopsy techniques cannot guarantee the exact location of lung tumours, so biopsies can be taken from healthy tissue. The BioSpy System (BSS) is a device with a probe, which is placed inside a normal biopsy needle. The tip of the probe contains sensors, that will scan the composition of the tissue which is in contact with the sensors. The INSPECT study aims at collecting the sensor data, with the goal of being able to differentiate the different tissues. All study participants will have a biopsy with the BSS. Participants will have a hospital visit for the procedure, and will have to stay up to 16 hours after their procedure as per normal hospital practice.
Phase
N/ASpan
53 weeksSponsor
SensomeLe Plessis-Robinson
Recruiting
Zenith Thoracic Alpha (ZTA) Post-Market Data Collection
Per local regulations, this study includes both retrospective and prospective patients. Patients can be included retrospectively if they are treated with the study device from 01 January 2019 until the study site is eligible for prospective enrollment.
Phase
N/ASpan
587 weeksSponsor
Cook Research IncorporatedLe Plessis-Robinson
Recruiting
European Aortic Data Collection Project
Phase
N/ASpan
396 weeksSponsor
Cook Research IncorporatedLe Plessis-Robinson
Recruiting
Immunologic Risk of Pregnancy in Women With Lung Transplantion : a National Multicentric Study
Phase
N/ASpan
57 weeksSponsor
Nantes University HospitalLe Plessis-Robinson
Recruiting
Healthy Volunteers
Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF)
Botulinium toxin use has been developed with success in wide-ranging fields (neurology, otorhinolaryngology, gynaecology, urology, plastic surgery, pain therapy), but not in cardiology. In the cardio-vascular field, only one pilot study on man has shown its utility in the prevention of atrial fibrillation by blocking the triggering through the sympathic and parasympathic systems. The investigators need to assess its potential benefits to prevent postoperative atrial tachyarrhythmia in a randomised multicentre study, with an expected impact of approximately 30,000 patients per years in France undergoing these types of cardiac surgery. The investigators hypothesize that botulinum toxin injection may substantially reduce postoperative AF during the first 3 weeks after cardiac surgery without any serious adverse events. By the suppression of ganglionic plexi (GP) activity in the epicardial fat pads, mild term antiarrhythmic effects can be achieved with fewer antiarrhythmic drugs and anticoagulant treatment.
Phase
3Span
366 weeksSponsor
Assistance Publique - Hôpitaux de ParisLe Plessis-Robinson
Recruiting
Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19
The main objective of this study is to evaluate the hospital survival of COVID-19 patients supported by venovenous or venoarterial ECMO in a multicenter registry. The secondary objectives are to describe the characteristics of COVID-19 patients who have received ECMO support, to identify the risk factors associated with hospital mortality, to analyze the outcomes after ECMO weaning including survival at day 28 and day 90, and to analyze the utility of a circulatory support mobile unit in a severe pandemic Inclusions are both prospective and retrospective in order to collect data over the whole pandemic
Phase
N/ASpan
27 weeksSponsor
Rennes University HospitalLe Plessis-Robinson
Recruiting
Hypnosis Versus SIVOC by Remifentanil During TAVI Procedures : Iloact on Peripoperative Confusion
Each included patient will randomly be assigned either to the hypnosis group or to the remifentanil group. Patients of the hypnosis group will have one preoperative and one perioperative hypnosis session with a qualified anesthesiologist. Patients of the remifentanil group will receive sedation with remifentanil, administered using a pre specified target controlled-infusion protocol. Incidence of delirium will be recorded in the cardiac intensive care unit (CICU) during the first 72 postoperative hours, using the Confusion Assessment Method in the ICU (CAM-ICU). Incidence of other complications such as episodes of oxygen desaturation, vascular wound, stroke, general anesthesia requirement and inhospital death will be recorded, as well as procedure duration, hospital length of stay, patient satisfaction and operator comfort. Transcatheter aortic valve implantation (TAVI) procedures are frequently complicated with postoperative delirium.
Phase
N/ASpan
157 weeksSponsor
Centre Chirurgical Marie LannelongueLe Plessis-Robinson
Recruiting
Evaluation of Diaphragmatic Function After Bi-pulmonary Transplantation
Phase
N/ASpan
105 weeksSponsor
Centre Chirurgical Marie LannelongueLe Plessis-Robinson
Recruiting
Lung Transplantation for Pleuroparenchymal Fibroelastosis
Phase
N/ASpan
31 weeksSponsor
Hospices Civils de LyonLe Plessis-Robinson
Recruiting
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
Phase
3Span
294 weeksSponsor
TakedaLe Plessis-Robinson
Recruiting